A detailed history of Financial Enhancement Group LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Financial Enhancement Group LLC holds 4,485 shares of BSX stock, worth $379,206. This represents 0.06% of its overall portfolio holdings.

Number of Shares
4,485
Previous 4,463 0.49%
Holding current value
$379,206
Previous $305,000 13.11%
% of portfolio
0.06%
Previous 0.06%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024

BUY
$67.33 - $77.71 $1,481 - $1,709
22 Added 0.49%
4,485 $345,000
Q1 2024

Apr 15, 2024

BUY
$57.6 - $68.62 $864 - $1,029
15 Added 0.34%
4,463 $305,000
Q2 2019

Aug 06, 2019

BUY
$34.91 - $42.98 $155,279 - $191,175
4,448 New
4,448 $191,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $121B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Financial Enhancement Group LLC Portfolio

Follow Financial Enhancement Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Enhancement Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Financial Enhancement Group LLC with notifications on news.